Zacks Research Has Bullish Estimate for McKesson Q3 Earnings

McKesson Co. (NYSE:MCK) – Analysts at Zacks Research upped their Q3 2025 earnings per share estimates for shares of McKesson in a research report issued on Wednesday, November 27th. Zacks Research analyst R. Department now forecasts that the company will earn $8.30 per share for the quarter, up from their prior forecast of $8.24. The consensus estimate for McKesson’s current full-year earnings is $32.73 per share. Zacks Research also issued estimates for McKesson’s Q4 2025 earnings at $9.17 EPS, FY2025 earnings at $32.43 EPS, Q1 2026 earnings at $7.92 EPS, Q3 2026 earnings at $10.02 EPS and Q4 2026 earnings at $8.99 EPS.

Several other brokerages have also issued reports on MCK. JPMorgan Chase & Co. upped their price target on McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research note on Wednesday, September 25th. Citigroup raised their price target on McKesson from $630.00 to $713.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Baird R W upgraded McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Finally, Mizuho lifted their price objective on shares of McKesson from $540.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $631.57.

McKesson Price Performance

MCK stock opened at $628.50 on Monday. The stock has a market capitalization of $79.78 billion, a PE ratio of 32.55, a price-to-earnings-growth ratio of 1.36 and a beta of 0.44. The company has a 50 day moving average price of $542.22 and a 200 day moving average price of $560.02. McKesson has a fifty-two week low of $431.35 and a fifty-two week high of $637.51.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business had revenue of $93.65 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period in the previous year, the business posted $6.23 earnings per share. The firm’s revenue for the quarter was up 21.3% compared to the same quarter last year.

Institutional Trading of McKesson

Hedge funds and other institutional investors have recently modified their holdings of the stock. Old North State Trust LLC increased its holdings in McKesson by 1.6% during the third quarter. Old North State Trust LLC now owns 1,138 shares of the company’s stock worth $563,000 after buying an additional 18 shares during the last quarter. Synovus Financial Corp increased its stake in shares of McKesson by 5.1% during the 3rd quarter. Synovus Financial Corp now owns 3,391 shares of the company’s stock worth $1,678,000 after purchasing an additional 166 shares during the last quarter. Castellan Group increased its stake in shares of McKesson by 4.0% during the 3rd quarter. Castellan Group now owns 10,200 shares of the company’s stock worth $5,043,000 after purchasing an additional 391 shares during the last quarter. Tidal Investments LLC raised its holdings in shares of McKesson by 453.8% in the 3rd quarter. Tidal Investments LLC now owns 52,992 shares of the company’s stock valued at $26,200,000 after purchasing an additional 43,424 shares during the period. Finally, Wilmington Savings Fund Society FSB lifted its stake in McKesson by 817.1% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,622 shares of the company’s stock valued at $2,780,000 after purchasing an additional 5,009 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insiders Place Their Bets

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the sale, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at $44,094,604.60. The trade was a 4.56 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.11% of the company’s stock.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd will be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend is Monday, December 2nd. McKesson’s payout ratio is 14.71%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.